Abstract Deadline Extended for CBS/CSPS/CC-CRS Conference
0 comments
by
Dear members and friends of the Canadian Biomaterials Society, The abstract deadline has been extended to March 2nd, 2026 for the upcoming CBS CCPS cc-CRS 2026 meeting this June in Vancouver, BC...
Dear friends , For this years annual meeting in beautiful Vancouver, BC June 2 - 5 2026 we are happy to partner with the Canadian Society for Pharmaceutical Sciences CSPS and the Canadian Chapter of the Controlled Release Society cc-CRS ...
Call for Abstracts for CBS/CSPS/cc-CRS Conference is now open!
0 comments
by
Call for Abstracts is OPEN The Canadian Biomaterials Society CBS , the Canadian Society for Pharmaceutical Sciences CSPS , and the Controlled Release Society cc-CRS are joining forces to host a landmark joint conference at UBC Vancouver...
Save the Date for CBS2026! June 2–5, 2026
0 comments
by
Overview The Canadian Biomaterials Society CBS , the Canadian Society for Pharmaceutical Sciences CSPS , and the Controlled Release Society cc-CRS are joining forces to host a landmark joint conference at UBC Vancouver...
Since thirty years, efforts were put forward to engineer materials that could be used to build up biomedical devices that have to come in contact with human tissues...
Localized Delivery of Exogenous C-type Natriuretic Peptide from Heparin-Coated NPs – Potential Use in Suppressing Fibrotic Phenotypes in Cardiac Myofibrogenesis
comments
In a healthy heart, cells naturally secrete C-type natriuretic peptide CNP , an anti-fibrotic cytokine that has strong effects on cardiac fibroblast function, fibrosis, and extracellular matrix deposition...
Solvent-controlled nanoparticle formation towards the generation of a robust long-acting lubricious antibiofilm coating for objects with complex geometries
comments
Developing safe and efficient strategies to deliver CRISPR-Cas9 clustered regularly interspaced palindromic repeats-CRISPR associated protein 9 complexes into cells has grown in importance over recent years, with an increasing demand for non-viral methods to enable clinical translation...